Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 38 Melanoma 15 Neoplasm Metastasis 12 Squamous Cell Carcinoma of Head and Neck 11 Lung Neoplasms 11 Skin Neoplasms 10 Neoplasms 9 Ovarian Neoplasms 8 Recurrence 7 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Urinary Bladder Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Basal Cell 6 Breast Neoplasms 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Squamous Cell 5 Carcinoma, Merkel Cell 5 Carcinoma 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Mouth Neoplasms 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Stomach Neoplasms 3 Sarcoma 3 Mycosis Fungoides 3

Interventions

liposomal doxorubicin 1 cemiplimab 1 Radiotherapy 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Invasive Breast Cancer × cemiplimab × 1 year × Clear all

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡